Department of Error (DOI:10.1016/S0140-6736(05)67530-7);Cholangiocarcinoma

Lancet

Volumn 366, Issue 9493, 2005, Pages 1303-1314

  Khan, Shahid A ^a   Thomas, Howard C ^a   Davidson, Brian R ^b   Taylor Robinson, Simon D ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CAPECITABINE; CISPLATIN; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; METHOTREXATE; MITOMYCIN C; OXALIPLATIN; REBECCAMYCIN;

ADJUVANT CHEMOTHERAPY; BILE DUCT CARCINOMA; BILIARY TRACT DRAINAGE; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC IMAGING; ENDOSCOPIC ECHOGRAPHY; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; HEREDITY; HUMAN; LIVER TRANSPLANTATION; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; STENT; SURVIVAL TIME;

EID: 26244441537     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68733-3     Document Type: Erratum

References (126)

1. MJ Olnes, R Erlich A review and update on cholangiocarcinoma Oncology 66 2004 167 179
2. KG Ishak, PP Anthony, LH Sobin Histological typing of tumours of the liver. WHO International Histological Classification of Tumours 1994 Springer Verlag Berlin
3. MT Carriaga, DE Henson Liver, gallbladder, extrahepatic bile ducts, and pancreas Cancer 75 1 1995 171 190
4. Y Shaib, HB El-Serag The epidemiology of cholangiocarcinoma Semin Liver Dis 24 2004 115 125
5. SA Khan, SD Taylor-Robinson, MB Toledano, A Beck, P Elliott, HC Thomas Changing international trends in mortality rates for liver, biliary and pancreatic tumours J Hepatol 37 2002 806 813
6. T Patel Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States Hepatology 33 2001 1353 1357
7. T Patel Worldwide trends in mortality from biliary tract malignancies BMC Cancer 2 2002 10
8. SD Taylor-Robinson, MB Toledano, S Arora Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998 Gut 48 2001 816 820
9. KG Ishak, PP Anthony, LH Sobin Histological typing of tumours of the liver. WHO International Histological Classification of Tumours 1994 Springer Verlag Berlin
10. A Nakeeb, HA Pitt, TA Sohn Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors Ann Surg 224 1996 463 473
11. SA Khan, BR Davidson, R Goldin Guidelines for the diagnosis and management of cholangiocarcinoma Gut 51 S6 2002 VI1 VI9
12. Liver Cancer Study Group of Japan The general rules for the clinical and pathological study of primary liver cancer 4th edn. 2000 Kanehra Tokyo
13. JN Vauthey, LH Blumgart Recent advances in the management of cholangiocarcinomas Semin Liver Dis 14 1994 109 114
14. YH Shaib, HB El-Serag, JA Davila, R Morgan, KA McGlynn Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study Gastroenterology 128 2005 620 626
15. A Tullo, AM D'Erchia, K Honda New p53 mutations in hilar cholangiocarcinoma Eur J Clin Invest 30 2000 798 803
16. YH Shaib, JA Davila, K McGlynn, HB El-Serag Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 40 2004 472 477
17. U Broome, R Olsson, L Loof Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis Gut 38 1996 610 615
18. HA Pitt, WC Dooley, CJ Yeo, JL Cameron Malignancies of the biliary tree Curr Probl Surg 32 1995 1 90
19. A Bergquist, H Glaumann, B Persson, U Broome Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study Hepatology 27 1998 311 316
20. N Chalasani, A Baluyut, A Ismail Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study Hepatology 31 2000 7 11
21. P Watanapa, WB Watanapa Liver fluke-associated cholangiocarcinoma Br J Surg 89 2002 962 970
22. P Watanapa Cholangiocarcinoma in patients with opisthorchiasis Br J Surg 83 1996 1062 1064
23. DM Parkin, P Srivatanakul, M Khlat Liver cancer in Thailand I: a case-control study of cholangiocarcinoma Int J Cancer 48 1991 323 328
24. W Thamavit, N Bhamarapravati, S Sahaphong, S Vajrasthira, S Angsubhakorn Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters Cancer Res 38 1978 4634 4639
25. DM Simeone Gallbladder and biliary tree: anatomy and structural anomalies T Yamada Textbook of gastroenterology 1999 Lippincott Willimas and Wilkins Philadelphia 2244 2257
26. J Scott, S Shousha, HC Thomas, S Sherlock Bile duct carcinoma: a late complication of congenital hepatic fibrosis: case report and review of literature Am J Gastroenterol 73 1980 113 119
27. PA Lipsett, HA Pitt, PM Colombani, JK Boitnott, JL Cameron Choledochal cyst disease: a changing pattern of presentation Ann Surg 220 1994 644 652
28. T Ohtsuka, K Inoue, J Ohuchida Carcinoma arising in choledochocele Endoscopy 33 2001 614 619
29. SW van Mil, LW Klomp, LN Bull, RH Houwen FIC1 disease: a spectrum of intrahepatic cholestatic disorders Semin Liver Dis 21 2001 535 544
30. E Jacquemin Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases Semin Liver Dis 21 2001 551 562
31. R Thompson, S Strautnieks BSEP: function and role in progressive familial intrahepatic cholestasis Semin Liver Dis. 21 2001 545 550
32. Y Meier, B Stieger, L Moore Hepatocellular malignancy in ABCB11/BStP disease (progressive familial intrahepatic cholestasis, type 2): four patients Hepatology 40 supp1 1 2004 471A
33. S Kubo, H Kinoshita, K Hirohashi, H Hamba Hepatolithiasis associated with cholangiocarcinoma World J Surg 19 1995 637 641
34. MF Chen Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment J Gastroenterol Hepatol 14 1999 1144 1149
35. K Okuda, Y Nakanuma, M Miyazaki Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology J Gastroenterol Hepatol 17 2002 1049 1055
36. 32P postlabelling, in human cholangiocarcinoma Gut 52 2003 586 591
37. D Sahani, SR Prasad, KK Tannabe, PF Hahn, PR Mueller, S Saini Thorotrast-induced cholangiocarcinoma: case report Abdom Imaging 28 2003 72 74
38. L Hardell, NO Bengtsson, U Jonsson, S Eriksson, LG Larsson Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria: an epidemiological investigation Br J Cancer 50 1984 389 397
39. HT Sorensen, S Friis, JH Olsen Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark Hepatology 28 1998 921 925
40. HR Shin, CU Lee, HJ Park Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea Int J Epidemiol 25 1996 933 940
41. F Donato, U Gelatti, A Tagger Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy Cancer Causes Control 12 2001 959 964
42. M Kobayashi, K Ikeda, S Saitoh Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis Cancer 88 2000 2471 2477
43. F Yin, B Chen Detection of hepatitis C virus RNA sequences in hepatic portal cholangiocarcinoma tissue by reverse transcription polymerase chain reaction Chin Med J (Engl) 111 1998 1068 1070
44. EP Berthiaume, J Wands The molecular pathogenesis of cholangiocarcinoma Semin Liver Dis 24 2004 127 137
45. O Nehls, M Gregor, B Klump Serum and bile markers for cholangiocarcinoma Semin Liver Dis 24 2004 139 154
46. T Isa, S Tomita, A Nakachi Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma Hepatogastroenterol 49 2002 604 608
47. Y Wang, Y Yamaguchi, H Watanabe, K Ohtsubo, T Wakabayashi, N Sawabu Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K-ras mutation J Gastroenterol 37 2002 831 839
48. T Itoi, K Takei, Y Shinohara K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers Pathol Int 49 1999 30 37
49. SI Aishima, KI Taguchi, K Sugimachi, M Shimada, K Sugimachi, M Tsuneyoshi c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma Histopathology 40 2002 269 278
50. DM Harnois, FG Que, A Celli, NF LaRusso, GJ Gores Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line Hepatology 26 1997 884 890
51. A Okaro, A Deery, R Hutchins, BR Davidson The expression of anti-apoptotic proteins (Bcl-2, Bcl-xl, Mcl-1) by benign, dysplastic and malignant biliary epithelium J Clin Pathol 54 2001 927 932
52. INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma Gastroenterol 123 2002 1090 1098
53. DJ van Leeuwen, JW Reeders Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma Ann Oncol 10 Suppl 4 1999 89 93
54. WR Jarnagin, M Shoup Surgical management of cholangiocarcinoma Semin Liver Dis 24 2004 189 199
55. CD Anderson, CW Pinson, J Berlin, RS Chari Diagnosis and treatment of cholangiocarcinoma Oncologist 9 2004 43 57
56. AH Patel, DM Harnois, GG Klee, NF LaRusso, GJ Gores The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis Am J Gastroenterol 95 2000 204 207
57. R Lamerz Role of tumour markers, cytogenetics Ann Oncol 10 suppl 4 1999 145 149
58. MB Albert, WM Steinberg, JP Henry Elevated serum levels of tumor marker CA19-9 in acute cholangitis Dig Dis Sci 33 1988 1223 1225
59. E Siqueira, RE Schoen, W Silverman Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis Gastrointest Endosc 56 2002 40 47
60. JK Ramage, A Donaghy, JM Farrant, R Iorns, R Williams Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis Gastroenterol 108 1995 865 869
61. S Saini Imaging of the hepatobiliary tract N Engl J Med 336 1997 1889 1894
62. C Valls, A Guma, I Puig Intrahepatic peripheral cholangiocarcinoma: CT evaluation Abdom Imaging 25 2000 490 496
63. Y Zhang, M Uchida, T Abe, H Nishimura, N Hayabuchi, Y Nakashima Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI J Comput Assist Tomogr 23 1999 670 677
64. TS Yeh, YY Jan, JH Tseng Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings Am J Gastroenterol 95 2000 432 440
65. R Manfredi, B Barbaro, G Masselli, A Vecchioli, P Marano Magnetic resonance imaging of cholangiocarcinoma Semin Liver Dis 24 2004 155 164
66. R Manfredi, MG Brizi, G Masselli, A Vecchioli, P Marano [Malignant biliary hilar stenosis: MR cholangiography compared with direct cholangiography] Radiol Med (Torino) 102 2001 48 54
67. SH Zidi, F Prat, O Le Guen, Y Rondeau, G Pelletier Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures Gut 46 2000 103 106
68. TH Baron, GC Harewood, A Rumalla A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures Clin Gastroenterol Hepatol 2 2004 214 219
69. EM Abu-Hamda, TH Baron Endoscopic management of cholangiocarcinoma Semin Liver Dis 24 2004 165 175
70. CD Anderson, MH Rice, CW Pinson, WC Chapman, RS Chari, D Delbeke Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma J Gastrointest Surg 8 2004 90 97
71. T Kato, E Tsukamoto, Y Kuge Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer Eur J Nucl Med Mol Imaging 29 2002 1047 1054
72. YJ Kim, M Yun, WJ Lee, KS Kim, JD Lee Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma Eur J Nucl Med Mol Imaging 30 2003 1467 1472
73. A Fritscher-Ravens, KH Bohuslavizki, DC Broering FDG PET in the diagnosis of hilar cholangiocarcinoma Nucl Med Commun 22 2001 1277 1285
74. H Bismuth, R Nakache, T Diamond Management strategies in resection for hilar cholangiocarcinoma Ann Surg 215 1992 31 38
75. EC Burke, WR Jarnagin, SN Hochwald, PW Pisters, Y Fong, LH Blumgart Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system Ann Surg 228 1998 385 394
76. WR Jarnagin, Y Fong, RP DeMatteo Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma Ann Surg 234 2001 507 517
77. T Ebata, M Nagino, J Kamiya, K Uesaka, T Nagasaka, Y Nimura Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases Ann Surg 238 2003 720 727
78. CU Corvera, SM Weber, WR Jarnagin Role of laparoscopy in the evaluation of biliary tract cancer Surg Oncol Clin N Am 11 2002 877 891
79. CH Su, SH Tsay, CC Wu Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma Ann Surg 223 1996 384 394
80. JL Cameron, HA Pitt, MJ Zinner, SL Kaufman, J Coleman Management of proximal cholangiocarcinomas by surgical resection and radiotherapy Am J Surg 159 1990 91 97
81. Y Nimura, N Hayakawa, J Kamiya, S Kondo, S Shionoya Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus World J Surg 14 1990 535 543
82. A Nakeeb, KQ Tran, MJ Black Improved survival in resected biliary malignancies Surgery 132 2002 555 563
83. Y Nimura, J Kamiya, S Kondo Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience J Hepatobiliary Pancreat Surg 7 2000 155 162
84. NS Hadjis, JI Blenkharn, N Alexander, IS Benjamin, LH Blumgart Outcome of radical surgery in hilar cholangiocarcinoma Surgery 107 1990 597 604
85. R Pichlmayr, A Weimann, J Klempnauer Surgical treatment in proximal bile duct cancer: a single-center experience Ann Surg 224 1996 628 638
86. KD Lillemoe, JL Cameron Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach. J Hepatobiliary Pancreat Surg 7 2000 115 121
87. Y Fong, LH Blumgart, E Lin, JG Fortner, MF Brennan Outcome of treatment for distal bile duct cancer Br J Surg 83 1996 1712 1715
88. TP Wade, CN Prasad, KS Virgo, FE Johnson Experience with distal bile duct cancers in U.S. Veterans Affairs hospitals: 1987-1991 J Surg Oncol 64 1997 242 245
89. Y Kitagawa, M Nagino, J Kamiya Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and para-aortic node dissection Ann Surg 233 2001 385 392
90. J Figueras, L Llado, C Valls Changing strategies in diagnosis and management of hilar cholangiocarcinoma Liver Transpl 6 2000 786 794
91. AW Hemming, AI Reed, RJ Howard Preoperative portal vein embolization for extended hepatectomy Ann Surg 237 2003 686 691
92. EK Abdalla, CC Barnett, D Doherty, SA Curley, JN Vauthey Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization Arch Surg 137 2002 675 680
93. T Todoroki, K Ohara, T Kawamoto Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma Int J Radiat Oncol Biol Phys 46 2000 581 587
94. D Gonzalez Gonzalez, DJ Gouma Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma Ann Oncol 10 Suppl 4 1999 215 220
95. HA Pitt, A Nakeeb, RA Abrams Perihilar cholangiocarcinoma: postoperative radiotherapy does not improve survival Ann Surg 221 1995 788 797
96. CG Meyer, I Penn, L James Liver transplantation for cholangiocarcinoma: results in 207 patients Transplantation 69 2000 1633 1637
97. DR Jeyarajah, GB Klintmalm Is liver transplantation indicated for cholangiocarcinoma? J Hepatobiliary Pancreat Surg 5 1998 48 51
98. JK Heimbach, GJ Gores, MG Haddock Liver transplantation for unresectable perihilar cholangiocarcinoma Semin Liver Dis 24 2004 201 207
99. DR Farley, AL Weaver, DM Nagorney "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention Mayo Clin Proc 70 1995 425 429
100. F Berr Photodynamic therapy for cholangiocarcinoma Semin Liver Dis 24 2004 177 187
101. WH Chang, P Kortan, GB Haber Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage Gastrointest Endosc 47 1998 354 362
102. RS Chari, CA Anderson, DMF Saverese Treatment of cholangiocarcinoma II BD Rose Up To Date 2003 UpToDate Wellesley, MA
103. F Prat, O Chapat, B Ducot Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline Gut 42 1998 76 80
104. KL Cheung, EC Lai Endoscopic stenting for malignant biliary obstruction Arch Surg 130 1995 204 207
105. W Schima, R Prokesch, C Osterreicher Biliary Wallstent endoprosthesis in malignant hilar obstruction: long-term results with regard to the type of obstruction Clin Radiol 52 1997 213 219
106. M Kaassis, J Boyer, R Dumas Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study Gastrointest Endosc 57 2003 178 182
107. JF Dowsett, D Vaira, AR Hatfield Endoscopic biliary therapy using the combined percutaneous and endoscopic technique Gastroenterol 96 1989 1180 1186
108. J Deviere, M Baize, J de Toeuf, M Cremer Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage Gastrointest Endosc 34 1988 95 101
109. GD De Palma, G Galloro, S Siciliano, P Iovino, C Catanzano Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study Gastrointest Endosc 53 2001 547 553
110. GD De Palma, A Pezzullo, M Rega Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study Gastrointest Endosc 58 2003 50 53
111. ML Freeman, C Overby Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents Gastrointest Endosc 58 2003 41 49
112. H Isayama, Y Komatsu, T Tsujino A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction Gut 53 2004 729 734
113. J Sung Commentary Nature Clin Prac, Gastro & Hep 1 2004 21
114. H Ohnishi, M Asada, Y Shichijo External radiotherapy for biliary decompression of hilar cholangiocarcinoma Hepatogastroenterol 42 1995 265 268
115. MF Gerhards, TM van Gulik, D Gonzalez Gonzalez, EA Rauws, DJ Gouma Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma World J Surg 27 2003 173 179
116. YZ Patt, MM Hassan, RD Lozano Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer Clin Cancer Res 7 2001 3375 3380
117. CW Choi, IK Choi, JH Seo Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas Am J Clin Oncol 23 2000 425 428
118. M Ducreux, P Rougier, A Fandi Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin Ann Oncol 9 1998 653 656
119. PA Ellis, A Norman, A Hill Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours Eur J Cancer 31A 1995 1594 1598
120. O Nehls, B Klump, HT Arkenau Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial Br J Cancer 87 2002 702 704
121. V Gebbia, F Giuliani, E Maiello Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study J Clin Oncol 19 2001 4089 4091
122. P Papakostas, C Kouroussis, N Androulakis First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract: a multicentre phase II study Eur J Cancer 37 2001 1833 1838
123. A Dowlati, J Posey, RK Ramanathan Multicenter phase II and pharmacokinetic study of rebeccamycin analogue in advanced biliary cancers Proc Am Soc Clin Oncol 22 2003 267a
124. S Thongprasert, S Napapan, C Charoentum, S Moonprakan Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma Ann Oncol 16 2005 279 281
125. JJ Knox, D Hedley, A Oza Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial J Clin Oncol 23 1 2005 2332 2338
126. ME Ortner, K Caca, F Berr Successful photodynamic therapy for non-resectable cholangiocarcinoma: a randomized prospective study Gastroenterol 125 2003 1355 1363